Hyperbaric oxygen therapy and stem cell study
Part of Blood & lymphatic clinical trials.
This study checks if hyperbaric oxygen therapy (HBOT) increases the number of stem cells circulating in your blood. You may qualify if you are already scheduled for HBOT for another reason and are willing to give blood samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 20 and 80 years old
- Already planning to start HBOT for another medical condition
- Willing to give blood samples for stem cell measurement
- No active or recent infection (within the last month)
- No active cancer, blood disease, or low vitamin B12/iron levels
- White blood cell count between 4,000 and 10,000
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial studies whether breathing pure oxygen in a pressurized chamber, along with a donor stem cell transplant, can improve outcomes for certain blood cancers. It may help by supporting the body during transplant and recovery, but it is still being tested for safety and effectiveness.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
This study observes how blood and stem cell transplants work for patients with blood diseases at high altitude. It aims to learn more to help future patients.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
This trial looks at blood “biomarkers,” or lab measurements, while people receive hyperbaric oxygen treatment for brain injury as part of the main HOBIT study. It may help researchers understand who benefits and why by improving how treatment responses are tracked.
Hear when a new Circulating Hematopoietic Stem Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.